Cargando…
Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases
Although these conditions are rare, a proportion of patients with interstitial lung diseases (ILDs) may develop a progressive-fibrosing phenotype. Progressive fibrosis is associated with worsening respiratory symptoms, lung function decline, limited response to immunomodulatory therapies, decreased...
Autores principales: | Cottin, Vincent, Hirani, Nikhil A., Hotchkin, David L., Nambiar, Anoop M., Ogura, Takashi, Otaola, María, Skowasch, Dirk, Park, Jong Sun, Poonyagariyagorn, Hataya K., Wuyts, Wim, Wells, Athol U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489068/ https://www.ncbi.nlm.nih.gov/pubmed/30578335 http://dx.doi.org/10.1183/16000617.0076-2018 |
Ejemplares similares
-
Management of Fibrosing Interstitial Lung Diseases
por: Maher, Toby M., et al.
Publicado: (2019) -
The natural history of progressive fibrosing interstitial lung diseases
por: Brown, Kevin K., et al.
Publicado: (2020) -
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
por: Cottin, Vincent, et al.
Publicado: (2021) -
Reply to comment on “The natural history of progressive fibrosing interstitial lung diseases”
por: Brown, Kevin K., et al.
Publicado: (2020) -
Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases
por: Brown, Kevin K., et al.
Publicado: (2022)